<p>Part 2 of HMP MAI’s podcast on value-based cancer care looking at how prevalent VBC is in primary and cancer care, private payer VBC activity specifically in oncology, and ideas about how biopharmaceutical manufacturers might adjust to shifting customer interests because of VBC.</p>

Part 2 of HMP MAI’s podcast on value-based cancer care looking at how prevalent VBC is in primary and cancer care, private payer VBC activity specifically in oncology, and ideas about how biopharmaceutical manufacturers might adjust to shifting customer interests because of VBC.

Oncology Value-Based Care: Risky Business (Part 2)

The pharmaceutical industry’s gold standard provider of market access insights. 

For clients of HMP Market Access Insights, Insights to Access features interviews with experts in the oncology management space.

Business

Medicine

Health & Fitness

Education

Management

The pharmaceutical industry’s gold standard provider of market access insights. For clients of HMP Market Access Insights, Insights to Access features interviews with experts in the oncology management space.

Share Oncology Value-Based Care: Risky Business (Part 2)

Sign up to save your podcasts

Oncology Value-Based Care: Risky Business (Part 2)

Oncology Value-Based Care: Risky Business (Part 2)